7 Results for "

HSP90-CDC37

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "HSP90-CDC37" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-139301
CAS No.: 2355377-13-6
Purity:  99.20%
Target:  

HSP

Research Areas:  

Cancer

DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-111414
CAS No.: 2227303-22-0
Purity:  99.66%
Target:  

HSP

Research Areas:  

Cancer

Hsp90-Cdc37-IN-1 is an Hsp90-Cdc37 interaction disruptor that inhibit cell migration and reverse agent resistance, with an IC50 of 140 nM.
loading...
    loading...
Cat. No.: HY-169947
CAS No.: 2648334-53-4
Target:  

CDK

Research Areas:  

Cancer

DDO-6079 is a potent CDC37 inhibitor. DDO-6079 inhibits HSP90-CDC37 and CDC37-CDK4/6 chaperone complex by binding to an allosteric site on CDC37. DDO-6079 decreases the thermostability of CDK6 .
loading...
    loading...
Cat. No.: HY-144650
CAS No.: 2361009-68-7
Purity:  98.09%
Target:  

Apoptosis HSP

Research Areas:  

Cancer

Hsp90-Cdc37-IN-3 (Compound 9) is a novel celastrol−imidazole derivative with anticancer activity. Hsp90-Cdc37-IN-3 inhibits Hsp90Cdc37 by covalent-binding, and induces apoptosis .
loading...
    loading...
Cat. No.: HY-119906
CAS No.: 72263-05-9
Purity:  95.48%
Synonyms: FW-04-806
Conglobatin (FW-04-806), a macrolide dilactone, is isolated from the culture of Streptomyces conglobatus. Conglobatin is an orally active Hsp90 inhibitor. Conglobatin can bind to the N-terminal domain of Hsp90 and disrupt Hsp90-Cdc37 complex formation. Conglobatin induces apoptosis in human breast cancer cells and esophageal squamous cell carcinoma cells, and exhibits antitumor activity in vivo .
loading...
    loading...
Cat. No.: HY-174347
CAS No.: 2758818-41-4
Research Areas:  

Cancer

Hsp90-Cdc37-IN-4, a Celastrol (HY-13067) derivative, inhibits the Hsp90-Cdc37 protein-protein interaction (PPI). Hsp90-Cdc37-IN-4 selectively inhibits casein kinase 2 (CK2), reducing phosphorylation of its substrate Cdc37 at Serine 13. Hsp90-Cdc37-IN-4 induces G0/G1 cell cycle arrest and triggers apoptosis via the mitochondrial pathway. Hsp90-Cdc37-IN-4 demonstrates potent anti-breast cancer activity .
loading...
    loading...
Cat. No.: HY-130624
CAS No.: 2413849-81-5
Target:  

HSP Apoptosis

Research Areas:  

Cancer

Hsp90-Cdc37-IN-2 (Compound 41) is an inhibitor for the interaction between heat shock protein 90 (Hsp90) and cyclin 37 (Cdc37). Hsp90-Cdc37-IN-2 inhibits the proliferation of cancer cell A549, MCF-7, HOS and HepG2 with IC50 of 0.41-0.94 μM. Hsp90-Cdc37-IN-2 decreases the mitochondrial membrane potential, induces apoptosis, and arrest cell cycle at G0/G1 phase in A549 .
loading...
    loading...